Metformin in cancer: translational challenges

Journal of Molecular Endocrinology
Ryan J O DowlingPamela J Goodwin

Abstract

The anti-diabetic drug metformin is rapidly emerging as a potential anti-cancer agent. Metformin, effective in treating type 2 diabetes and the insulin resistance syndromes, improves insulin resistance by reducing hepatic gluconeogenesis and by enhancing glucose uptake by skeletal muscle. Epidemiological studies have consistently associated metformin use with decreased cancer incidence and cancer-related mortality. Furthermore, numerous preclinical and clinical studies have demonstrated anti-cancer effects of metformin, leading to an explosion of interest in evaluating this agent in human cancer. The effects of metformin on circulating insulin levels indicate a potential efficacy towards cancers associated with hyperinsulinaemia; however, metformin may also directly inhibit tumour growth. In this review, we describe the mechanism of action of metformin and summarise the epidemiological, clinical and preclinical evidence supporting a role for metformin in the treatment of cancer. In addition, the challenges associated with translating preclinical results into therapeutic benefit in the clinical setting will be discussed.

Associated Clinical Trials

References

May 24, 1995·JAMA : the Journal of the American Medical Association·J Everhart, D Wright
May 1, 1996·Journal of Endocrinological Investigation·V Papa, A Belfiore
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pamela J GoodwinNicky Hood
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Jul 19, 2003·Genes & Development·Ken InokiKun-Liang Guan
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Isabelle Sansal, William R Sellers
Jul 16, 2004·Cancer Biology & Therapy·Kurtis E BachmanBen Ho Park
Jul 21, 2004·Cancer Cell·Reuben J ShawLewis C Cantley
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaoyan ZhouDihua Yu
Apr 26, 2005·BMJ : British Medical Journal·Josie M M EvansAndrew D Morris
May 4, 2005·Molecular Cell·Russell G JonesCraig B Thompson
Aug 13, 2005·Anti-cancer Drugs·Daniel Morgensztern, Howard L McLeod
Aug 30, 2005·Experimental Gerontology·Vladimir N AnisimovClaudio Franceschi
Nov 17, 2005·Journal of the National Cancer Institute·Susanna C LarssonAlicja Wolk
Feb 2, 2006·International Journal of Cancer. Journal International Du Cancer·Patrizia PasanisiSalvatore Panico
Jul 11, 2006·The Journal of Clinical Investigation·Yun Chau Long, Juleen R Zierath
Oct 6, 2006·Diabetologia·S C LarssonA Wolk
Oct 26, 2006·Cancer Research·Mahvash ZakikhaniMichael Pollak
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jocelyn S Kasper, Edward Giovannucci
Jan 16, 2007·Breast Cancer Research and Treatment·Anna Marie MulliganPamela J Goodwin
Apr 3, 2007·International Journal of Cancer. Journal International Du Cancer·Susanna C LarssonAlicja Wolk
Apr 21, 2007·Cellular and Molecular Life Sciences : CMLS·A IsakovicV Trajkovic
May 4, 2007·The Journal of Clinical Investigation·Yan ShuKathleen M Giacomini
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gizeh Pérez-TenorioOlle Stål
Sep 6, 2007·Cell Cycle·Lauren L Campbell, Kornelia Polyak
Apr 29, 2008·Breast Cancer Research and Treatment·Vuk StambolicPamela J Goodwin
Apr 29, 2008·Molecular Cell·Dana M GwinnReuben J Shaw
May 10, 2008·Archives of Physiology and Biochemistry·Paola Pisani
May 13, 2008·Endocrine-related Cancer·Carolyn AlgireMichael Pollak
Sep 23, 2008·Cancer Science·Ayako TomimotoAtsushi Nakajima
Nov 20, 2008·Journal of Mammary Gland Biology and Neoplasia·Antonino Belfiore, Francesco Frasca
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Nov 27, 2008·Diabetes Care·Joanna MitriAnastassios G Pittas

❮ Previous
Next ❯

Citations

Aug 1, 2012·Breast Cancer Research and Treatment·Nananda F ColRowan T Chlebowski
Apr 11, 2013·Breast Cancer Research and Treatment·C CampagnoliF Berrino
Aug 3, 2013·Cancer Metastasis Reviews·Jeff M P HollyClaire M Perks
Mar 19, 2013·European Journal of Pharmacology·Christos V Rizos, Moses S Elisaf
Jul 17, 2013·Nature Reviews. Clinical Oncology·Wenjing Tao, Jesper Lagergren
Nov 28, 2013·Cancer & Metabolism·Stephen D HurstingLaura M Lashinger
Oct 12, 2012·Molecular Endocrinology·Stephen D Hursting
Aug 28, 2012·Diabetes Care·Brielan B SmiechowskiSamy Suissa
Aug 29, 2013·International Journal of Endocrinology·Rosalyne L Westley, Felicity E B May
Nov 15, 2013·Journal of Carcinogenesis·Sneha SundaramLiza Makowski
Dec 5, 2012·ISRN Endocrinology·Edoardo Mannucci
Jun 25, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S JiralerspongS H Giordano
May 21, 2014·ELife·William W WheatonNavdeep S Chandel
Jul 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Andreas JanzerKevin Struhl
Jun 16, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ellena Badrick, Andrew G Renehan
Jul 24, 2014·Journal of the American Medical Informatics Association : JAMIA·Hua XuJoshua C Denny
Dec 18, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S M HadadA M Thompson
Aug 31, 2014·Hormones & Cancer·Elizabeth A Wellberg, Steven M Anderson
Nov 28, 2012·Women's Health·Julia A FilesSandhya Pruthi
Aug 1, 2015·International Journal of Molecular Sciences·Josephine S Modica-Napolitano, Volkmar Weissig
Aug 24, 2013·Expert Opinion on Investigational Drugs·Anna Spreafico, Helen J Mackay
Aug 28, 2013·Expert Opinion on Investigational Drugs·Joud HajjarAung Naing
Nov 26, 2014·Annual Review of Medicine·Pamela J Goodwin, Vuk Stambolic
Nov 19, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MitsuhashiM Shozu
Dec 3, 2014·Gynecologic Oncology·Terri FebbraroIris L Romero
Jan 7, 2016·Current Diabetes Reports·Asieh GolozarHsin-Chieh Yeh
Apr 10, 2013·Annales d'endocrinologie·Emmanuel Beck, André J Scheen
Aug 16, 2015·Tissue & Cell·Ahmed M KabelHany M Borg
Aug 14, 2012·Clinical Endocrinology·Maria Alevizaki
Oct 12, 2012·Annals of the New York Academy of Sciences·Ivana Vucenik, Joseph P Stains
Jun 20, 2014·Cancer Medicine·Bridget A OppongTari A King
Sep 4, 2015·Clinical Pharmacokinetics·Farshad KajbafJean-Daniel Lalau
Mar 7, 2014·Clinical Endocrinology·Callum Livingstone, Anwar Borai
Aug 2, 2014·International Journal of Cancer. Journal International Du Cancer·Floris H GroenendijkRené Bernards
Oct 17, 2013·Journal of Cellular Physiology·Min ShenQ Ping Dou
Dec 19, 2015·Oxidative Medicine and Cellular Longevity·Júlia SantosCecília Leão
Sep 13, 2015·Chemico-biological Interactions·Yining ZhaoXiaopeng Hu
Jan 26, 2016·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Dai FukumuraRakesh K Jain
Oct 3, 2015·Molecular Pharmaceutics·Xinbing SuiMang Xiao
Aug 15, 2015·Metabolism: Clinical and Experimental·Abbas ShafaeeMilad Hatamian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.